Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Donald M Jensen
Glecaprevir/Pibrentasvir for the Treatment of Chronic Hepatitis C: Design, Development, and Place in Therapy
Drug Design, Development and Therapy
Drug Discovery
Pharmacology
Pharmaceutical Science
Related publications
Effectiveness of 8-Week Glecaprevir/Pibrentasvir for Treatment-Naïve, Compensated Cirrhotic Patients With Chronic Hepatitis C Infection
Advances in Therapy
Medicine
Pharmacology
Glecaprevir and Pibrentasvir Combination Therapy for Hepatitis C Virus-Infected Japanese Patients on Hemodialysis
Renal Replacement Therapy
Efficacy of Glecaprevir and Pibrentasvir in Patients With Genotype 1 Hepatitis C Virus Infection With Treatment Failure After NS5A Inhibitor Plus Sofosbuvir Therapy
Gastroenterology
Hepatology
Gastroenterology
Glecaprevir/Pibrentasvir for 8 Weeks in Treatment-Naïve Patients With Chronic HCV Genotypes 1–6 and Compensated Cirrhosis: The EXPEDITION-8 Trial
Journal of Hepatology
Hepatology
Obinutuzumab in Chronic Lymphocytic Leukemia: Design, Development and Place in Therapy
Drug Design, Development and Therapy
Drug Discovery
Pharmacology
Pharmaceutical Science
Historical Treatment of Chronic Hepatitis B and Chronic Hepatitis C.
Gut
Gastroenterology
Benralizumab in the Treatment of Severe Asthma: Design, Development and Potential Place in Therapy
Drug Design, Development and Therapy
Drug Discovery
Pharmacology
Pharmaceutical Science
Recent Advances in Antiviral Therapy for Chronic Hepatitis C
Mediators of Inflammation
Immunology
Cell Biology
Osimertinib in the Treatment of Non-Small-Cell Lung Cancer: Design, Development and Place in Therapy
Lung Cancer: Targets and Therapy
Oncology
